Back
Inozyme Pharma Stock Price Chart
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Buy
74
INZY
Inozyme Pharma
Last Price:
3.02
Seasonality Move:
26.03%
7 Day Trial
ALL ACCESS PASS
$
7
The dark truth about AI
Click here to learn more...- The current trend is relatively stagnant and INZY is experiencing buying pressure, which is a positive indicator for future bullish movement.
Inozyme Pharma Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.8 | Buy |
| 20-day SMA: | 2.78 | Buy |
| 50-day SMA: | 3.93 | Sell |
| 200-day SMA: | 4.86 | Sell |
| 8-day EMA: | 2.88 | Buy |
| 20-day EMA: | 3.01 | Buy |
| 50-day EMA: | 3.65 | Sell |
| 200-day EMA: | 4.53 | Sell |
Inozyme Pharma Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 45.19 | Sell |
| Chaikin Money Flow: | 418736 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.55 - 3.41) | Buy |
| Bollinger Bands (100): | (3.54 - 5.6) | Sell |
Inozyme Pharma Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Inozyme Pharma Stock
Is Inozyme Pharma Stock a Buy?
- Inozyme Pharma share price is 3.03 while INZY 8-day simple moving average is 2.80, which is a Buy signal.
- The stock price of INZY is 3.03 while Inozyme Pharma 20-day SMA is 2.78, which makes it a Buy.
- Inozyme Pharma 50-day simple moving average is 3.93 while INZY share price is 3.03, making it a Sell technically.
- INZY stock price is 3.03 and Inozyme Pharma 200-day simple moving average is 4.86, creating a Sell signal.
INZY Technical Analysis vs Fundamental Analysis
Buy
74
Inozyme Pharma (INZY)
is a Buy
Is Inozyme Pharma a Buy or a Sell?
-
Inozyme Pharma stock is rated a Buy
The current Inozyme Pharma [INZY] share price is $3.03. The Score for INZY is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
Inozyme Pharma Stock Info
Market Cap:
194.65M
Price in USD:
3.03
Share Volume:
809.56K
Inozyme Pharma 52-Week Range
52-Week High:
7.80
52-Week Low:
2.39
Buy
74
Inozyme Pharma (INZY)
is a Buy
Inozyme Pharma Share Price Forecast
-
What is the Inozyme Pharma stock price today?
The Inozyme Pharma stock price is 3.03 USD today. -
Will INZY stock go up or go down?
Inozyme Pharma> share price is forecast to RISE/FALL based on technical indicators -
Is Inozyme Pharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Inozyme Pharma is not overvalued.
Is Inozyme Pharma Stock a Buy?
- Inozyme Pharma share price is 3.03 while INZY 8-day exponential moving average is 2.88, which is a Buy signal.
- The stock price of INZY is 3.03 while Inozyme Pharma 20-day EMA is 3.01, which makes it a Buy.
- Inozyme Pharma 50-day exponential moving average is 3.65 while INZY share price is 3.03, making it a Sell technically.
- INZY stock price is 3.03 and Inozyme Pharma 200-day simple moving average is 4.53, creating a Sell signal.
Fundamental Analysis of Inozyme Pharma
Is Inozyme Pharma a good investment?
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.03 per share.
Technical Analysis of Inozyme Pharma
Should I short Inozyme Pharma stock?
- INZY Moving Average Covergence Divergence (MACD) indicator is -0.27, suggesting Inozyme Pharma is a Sell
- Inozyme Pharma Relative Strength Index (RSI) is 45.19, which suggest Inozyme Pharma is oversold
- The Bollinger Bands (25) for Inozyme Pharma is (2.55 - 3.41), which suggest Inozyme Pharma is a Sell
- The Bollinger Bands (100) for Inozyme Pharma is (3.54 - 5.6), which suggest Inozyme Pharma is a Sell
* Inozyme Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.